Related Experiment Videos
Activated K-ras is involved in regulation of integrin expression in human colon carcinoma cells
K Schramm1, K Krause, A Bittroff-Leben
1Department of Hematology and Oncology, University Medical Center Benjamin Franklin, Free University, Berlin, Germany. tibet@mail.zedat.fu-berlin.de
Abstract:
Integrins participate in controlling proliferation and migration. Therefore, changes in integrin expression might be responsible for unrestrained proliferation and invasiveness of tumor cells. Alterations of integrin subunit expression have been observed in human colon carcinoma, especially loss or reduction of the alpha5 subunit, which was observed consistently. The mechanisms responsible for reduction of alpha5 expression and alteration of expression of other integrins are not fully understood. Circumstantial evidence from previous investigations points to an involvement of activated ras oncogenes in repression of integrin expression. The K-ras protooncogene is activated by point mutation in 50% of human colon carcinomas. Thus, we choose an antisense approach for specific inactivation of activated K-ras in the human colon carcinoma cell line SW 480 in order to test whether activated K-ras contributes to changes in integrin expression on colon carcinoma cells. Cell surface expression of the alpha1 and the alpha5 subunit was increased in K-ras antisense transfected clones, cell surface expression of the alpha3 subunit and the alphav subunit was decreased. This shows, in a human system, that activated K-ras is involved in diminishing cell surface expression of the alpha1beta1 collagen/laminin receptor and the alpha5beta1 fibronectin receptor, both of which are implicated in maintenance of a non-transformed phenotype. Moreover, activated K-ras contributes to increased cell surface expression of the alpha3beta1 laminin/collagen/fibronectin receptor and the alphavbeta5 vitronectin receptor, which might play a role in metastatic behavior of tumor cells.
Insights
Activated K-ras oncogenes in colon cancer cells reduce expression of integrins that maintain a non-transformed phenotype. This study used antisense technology to investigate K-ras
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Integrins regulate cell proliferation and migration, and their altered expression is linked to tumor cell invasiveness.
- Loss of the alpha5 integrin subunit is a consistent finding in human colon carcinoma.
- Activated K-ras oncogenes are implicated in repressing integrin expression in tumors.
Purpose of the Study:
- To investigate whether activated K-ras contributes to altered integrin expression in colon carcinoma cells.
- To determine the role of activated K-ras in regulating specific integrin subunits involved in tumor cell behavior.
Main Methods:
- Utilized an antisense approach to specifically inactivate activated K-ras in the SW 480 human colon carcinoma cell line.
- Analyzed cell surface expression of integrin subunits (alpha1, alpha3, alpha5, alphav) in K-ras antisense transfected cells.
Main Results:
- K-ras antisense transfection led to increased cell surface expression of alpha1 and alpha5 integrin subunits.
- Conversely, transfection resulted in decreased expression of alpha3 and alphav integrin subunits.
- Activated K-ras was shown to diminish expression of alpha1beta1 and alpha5beta1 receptors while increasing alpha3beta1 and alphavbeta5 receptor expression.
Conclusions:
- Activated K-ras plays a significant role in altering integrin expression in colon carcinoma cells.
- The findings suggest activated K-ras contributes to reduced expression of receptors associated with a non-transformed phenotype (alpha1beta1, alpha5beta1).
- Activated K-ras may promote tumor cell metastatic behavior through increased expression of alpha3beta1 and alphavbeta5 receptors.